Document is current
Any future updates will be listed below
-
Authors
Massen, Maartje
Lommen, Kim
Wouters, Kim A. D.
Vandersmissen, Johan
van Criekinge, Wim
Herman, James G.
Melotte, Veerle
Schouten, Leo J.
van Engeland, Manon
Smits, Kim M. https://orcid.org/0000-0003-2097-0533
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (UM-2-13-6075)
Stand Up To Cancer ((SU2C)-AACR- DT1415, MEDOCC)
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 7 April 2022
First Online: 27 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: MvE is cofounder and shareholder of Epify BV and MLA Diagnostics BV, and received grants from MDxHealth, outside the submitted work. In addition, MvE has a patent on DNA methylation markers for colorectal cancer detection.
